Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 560.0K | $3.0M | 1.51% | +494.9K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 488.0K | $3.0M | 1.31% | +121.9K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 470.5K | $3.0M | 1.27% | +212.5K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 270.6K | $1.0M | 0.73% | +156.0K | 2026-06-30 |
| Dauntless Investment Group, LLC | 203.9K | $1.0M | 0.55% | +113.3K | 2026-06-30 |
| STATE STREET CORP | 129.6K | -- | 0.35% | +78.8K | 2026-06-30 |
| NORTHERN TRUST CORP | 89.8K | -- | 0.24% | +65.1K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 81.4K | -- | 0.22% | -- | 2026-06-30 |
| EDGEWOOD MANAGEMENT LLC | 80.0K | -- | 0.22% | -20.0K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 79.5K | -- | 0.21% | +11.6K | 2026-06-30 |
